Baxter International Inc. (BAX)
$26.49+0.57%Close
BUYRECOVERY · day 76
Key stats
Short interest · FINRA settlement 2026-07-31
52-week IV17.3%–103.2%
- Market cap
- $13.7B
- Avg volume
- 7.1M
- Beta
- 0.59
- Div yield
- 0.76%
- P/E (TTM)
- -12.99
- IV-%ile
- 68
- IV ATM
- 49.0%
- Short % float
- 6.39%
- Days to cover
- 4.3
- SI change
- -11.3%
- 1W
- +2.24%
- 1M
- +18.26%
- 3M
- +38.11%
- YTD
- +35.85%
- vs SPY 1W
- +3.43%
- vs SPY 1M
- +14.94%
- vs SPY 3M
- +35.72%
- vs SPY YTD
- +24.09%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- MYOBUYMyomo, Inc.CRISISQ -9$1.39-19.65%
- EBSSELLEmergent BioSolutions Inc.CRISISQ 12$5.18+1.97%
- ANLBUYAdlai Nortye Ltd.RECOVERYQ 14$14.16+3.36%
- NXGLSELLNEXGEL, Inc.CRISISQ -13$0.38+15.15%
- HYFTBUYMindWalk Holdings Corp.RECOVERYQ 8$1.38-2.13%
- PPCBSELLPropanc Biopharma, Inc.CRISISQ -15$1.16+7.41%
- MOBISELLMobia Medical, Inc. Common StockQ -5$10.98+3.49%
- EUDASELLEUDA Health Holdings LimitedCRISISQ -9$15.40+16.58%
- CANFSELLCan-Fite BioPharma Ltd.RECOVERYQ -14$3.35+0.60%
- RAPPBUYRapport Therapeutics, Inc. Common StockBULLQ 38$49.33+2.26%
- BDSXBUYBiodesix, Inc.RECOVERYQ -9$25.39-4.66%
- ESPRBUYEsperion Therapeutics, Inc.BULLQ 1$3.18+0.00%
Industry peers
FMP comparable companies · ranked by market cap
- MDGLSELLMadrigal Pharmaceuticals, Inc.$11.9BRECOVERYQ 16$516.74-0.92%
- DVASELLDaVita Inc.$11.2BCRISISQ 10$173.82+1.54%
- BIOBUYBio-Rad Laboratories, Inc.$10.2BBULLQ 19$380.03+0.46%
- RGENBUYRepligen Corporation$10.2BBULLQ 26$181.13+0.27%
- AVTRBUYAvantor, Inc.$9.8BRECOVERYQ 2$14.46-1.38%
- MASIBUYMasimo Corporation$9.4BBULLQ 14$179.95+0.00%
- QGENBUYQiagen N.V.$9.1BRECOVERYQ 15$44.07-5.20%
- ATRSELLAptarGroup, Inc.$8.6BRECOVERYQ 16$134.80-0.04%
- HIMSBUYHims & Hers Health, Inc.$7.5BRECOVERYQ 20$33.78-7.99%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 5
- VALUE
- 0
- GROWTH
- 28
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-10.0%
REV YoY-
ROE-16.6%
EPS YoY-
ROA-5.4%
GROSS30
OP-2
NET-9
[VALUATION]
P/E TTM-12.99
P/E FWD-
SECTOR PE22.66
INDUSTRY PE41.50
P/B2.21
P/FCF-
EV/EBITDA28.28
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E155.77
ALTMAN Z-
CURR RATIO1.95
ND/EBITDA-
BETA0.59
